Latest statistics and disclosures from Aquilo Capital Management's latest quarterly 13F-HR filing:
- Top 5 stock holdings are XBI, IWM, SPRO, BPMC, DRNA, and represent 85.86% of Aquilo Capital Management's stock portfolio.
- Added to shares of these 7 stocks: IWM (+$255M), XBI (+$223M), SPRO (+$29M), BPMC (+$6.6M), MGTA (+$6.5M), ACIU, GMAB.
- Started 4 new stock positions in GMAB, ACIU, MGTA, IWM.
- Reduced shares in these 10 stocks: ARGX (-$7.4M), PIRS, MOR, QURE, ARWR, ANAB, GLPG, DRNA, NGM, RGNX.
- Sold out of its positions in MOR.
- Aquilo Capital Management was a net buyer of stock by $498M.
- Aquilo Capital Management has $945M in assets under management (AUM), dropping by 90.48%.
Tip: Access up to 7 years of quarterly data
Positions held by Aquilo Capital Management, LLC consolidated in one spreadsheet with up to 7 years of dataDownload as csv Download as Excel
Portfolio Holdings for Aquilo Capital Management
Companies in the Aquilo Capital Management portfolio as of the September 2020 quarterly 13F filing
|Company (Ticker)||Portfolio Weight||Valued At||Change in Shares||Share Count||Share Price|
|Spdr Ser Tr S&p Biotech Unit Put Option (XBI)||47.2||$446M||+100%||4.0M||111.43|
|Ishares Tr Russell 2000 Etf Unit Put Option (IWM)||27.0||$255M||NEW||1.7M||149.79|
|Spero Therapeutics (SPRO)||5.3||$50M||+131%||4.5M||11.16|
|Blueprint Medicines (BPMC)||3.8||$36M||+22%||386k||92.70|
|Dicerna Pharmaceuticals (DRNA)||2.6||$25M||-5%||1.4M||17.99|
|Uniqure Nv SHS (QURE)||2.5||$23M||-7%||631k||36.83|
|Arrowhead Pharmaceuticals (ARWR)||2.4||$23M||-7%||523k||43.06|
|Anaptysbio Inc Common (ANAB)||2.3||$22M||-7%||1.5M||14.75|
|Ngm Biopharmaceuticals (NGM)||1.7||$16M||-7%||1.0M||15.91|
|Regenxbio Inc equity us cm (RGNX)||1.5||$14M||-7%||511k||27.52|
|Proqr Thrapeutics N V Shs Euro (PRQR)||1.2||$11M||-4%||2.3M||4.79|
|Pieris Pharmaceuticals (PIRS)||0.8||$7.6M||-34%||3.7M||2.07|
|Magenta Therapeutics (MGTA)||0.7||$6.5M||NEW||959k||6.80|
|Galapagos Nv Spon Adr (GLPG)||0.5||$4.6M||-26%||33k||141.91|
Setup an alert
Aquilo Capital Management will file the next quarterly 13-HR in about 2 months. Would you like to be notified?
|Ac Immune Sa SHS (ACIU)||0.2||$2.3M||NEW||464k||4.88|
|Argenx Se Sponsored Adr (ARGX)||0.2||$2.0M||-79%||7.5k||262.53|
|Genmab A/s Sponsored Ads (GMAB)||0.2||$1.8M||NEW||50k||36.62|
Past Filings by Aquilo Capital Management
SEC 13F filings are viewable for Aquilo Capital Management going back to 2018
- Aquilo Capital Management 2020 Q3 filed Nov. 16, 2020
- Aquilo Capital Management 2020 Q2 filed Aug. 14, 2020
- Aquilo Capital Management 2020 Q1 filed May 15, 2020
- Aquilo Capital Management 2019 Q4 filed Feb. 14, 2020
- Aquilo Capital Management 2019 Q3 filed Nov. 14, 2019
- Aquilo Capital Management 2019 Q2 filed Aug. 14, 2019
- Aquilo Capital Management 2019 Q1 filed May 15, 2019
- Aquilo Capital Management 2018 Q4 filed Feb. 14, 2019